Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Double Cord Blood Transplant”

35 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 35 results

Testing effectiveness (Phase 2)WithdrawnNCT01652014
What this trial is testing

Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Lymphoblastic Leukemia in Remission+51 more
University of Medicine and Dentistry of New Jersey
Testing effectiveness (Phase 2)Study completedNCT00067002
What this trial is testing

Randomized Double Cord Blood Transplant Study

Who this might be right for
Leukemia, Lymphocytic, AcuteLeukemia, Myelocytic, AcuteLeukemia, Myeloid, Chronic+1 more
M.D. Anderson Cancer Center 110
Testing effectiveness (Phase 2)Study completedNCT01408563
What this trial is testing

Reduced Intensity Double Umbilical Cord Blood Transplantation

Who this might be right for
Non-Hodgkin's LymphomaHodgkin's LymphomaMultiple Myeloma+2 more
Massachusetts General Hospital 33
Testing effectiveness (Phase 2)Ended earlyNCT00871689
What this trial is testing

Chemotherapy, Total-Body Irradiation, Donor Natural Killer Cell Infusion, Aldesleukin, and UCB Transplant in Treating Patients With Relapsed or Refractory AML

Who this might be right for
Leukemia
Masonic Cancer Center, University of Minnesota 2
Testing effectiveness (Phase 2)Ended earlyNCT00801931
What this trial is testing

Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders

Who this might be right for
LeukemiaLymphomaNeuroblastoma+2 more
Columbia University 1
Testing effectiveness (Phase 2)Study completedNCT01690520
What this trial is testing

Donor Umbilical Cord Blood Transplant With or Without Ex-vivo Expanded Cord Blood Progenitor Cells in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, or Myelodysplastic Syndromes

Who this might be right for
Acute Biphenotypic LeukemiaAcute Lymphoblastic Leukemia in RemissionAcute Myeloid Leukemia in Remission+2 more
Nohla Therapeutics, Inc. 163
Testing effectiveness (Phase 2)WithdrawnNCT01882374
What this trial is testing

Efficacy Study of a TXA127 to Reduce Acute Graft-vs-Host Disease in Subjects Undergoing Double Umbilical Cord Blood Transplantation

Who this might be right for
Hematologic Malignancies
Tarix Pharmaceuticals
Large-scale testing (Phase 3)UnknownNCT01067300
What this trial is testing

A Study Comparing Single Versus Double Umbilical Cord Blood Transplantation in the Young With Acute Leukemia Remission

Who this might be right for
Leukemia
Assistance Publique Hopitaux De Marseille 198
Early research (Phase 1)Study completedNCT00890500
What this trial is testing

Safety and Efficacy of ProHema Modulated Umbilical Cord Blood Units in Subjects With Hematologic Malignancies.

Who this might be right for
Hematologic MalignanciesAllogeneic Stem Cell Transplantation
Fate Therapeutics 12
Early research (Phase 1)Ended earlyNCT00973804
What this trial is testing

Pilot Trial of Targeted Immune-Depleting Chemotherapy and Reduced-Intensity Matched Unrelated Double Cord Blood Transplant for the Treatment of Leukemias, Lymphomas, and Pre-Malignant Blood Disorders

Who this might be right for
LeukemiaNon-Hodgkins LymphomaHodgkins Lymphoma+2 more
National Cancer Institute (NCI) 4
Testing effectiveness (Phase 2)WithdrawnNCT01554254
What this trial is testing

Evaluation of the Safety and Efficacy of TXA127 (Angiotensin 1-7) to Enhance Engraftment in Pediatric Patients Undergoing Single or Double Umbilical Cord Blood Transplantation

Who this might be right for
Cord Blood TransplantHematologic MalignancyInherited Metabolic Disease
Tarix Pharmaceuticals
Early research (Phase 1)Ended earlyNCT01300611
What this trial is testing

TXA127 in Enhancement of Engraftment in Adult Double Cord Blood Transplantation

Who this might be right for
Double Cord Blood TransplantAcute Myelogenous LeukemiaMyelodysplastic Syndrome+6 more
Tarix Pharmaceuticals 20
Large-scale testing (Phase 3)Study completedNCT01597778
What this trial is testing

Double Cord Versus Haploidentical (BMT CTN 1101)

Who this might be right for
Acute Lymphocytic LeukemiaAcute Myelogenous LeukemiaBurkitt's Lymphoma+4 more
Medical College of Wisconsin 368
Testing effectiveness (Phase 2)Study completedNCT00597519
What this trial is testing

A Myeloablative Conditioning Regimen and Total Body Irradiation Followed by the Transplantation for Patients With Hematological Malignancy

Who this might be right for
CancerLeukemiaMyelodysplastic Syndrome+1 more
Memorial Sloan Kettering Cancer Center 28
Testing effectiveness (Phase 2)Study completedNCT00763490
What this trial is testing

Trial Of Double Umbilical Cord Blood Transplantation

Who this might be right for
Hematological Malignancies
University of Michigan Rogel Cancer Center 20
Testing effectiveness (Phase 2)UnknownNCT02385955
What this trial is testing

Phase II Study of Myeloablative Double Unit Umbilical Cord Blood Transplantation in Adult Patients

Who this might be right for
Hematologic Malignancy
Seoul National University Hospital 39
Testing effectiveness (Phase 2)Study completedNCT01471613
What this trial is testing

Lithium, Cord Blood Cells and the Combination in the Treatment of Acute & Sub-acute Spinal Cord Injury

Who this might be right for
Spinal Cord Injury
China Spinal Cord Injury Network 16
Testing effectiveness (Phase 2)Ended earlyNCT00295880
What this trial is testing

Donor Umbilical Cord Blood Transplant By Injection Into the Bone Marrow in Treating Patients With Hematologic Cancer

Who this might be right for
Myeloproliferative DisordersLeukemiaLymphoma+1 more
Masonic Cancer Center, University of Minnesota 12
Testing effectiveness (Phase 2)Ended earlyNCT01464359
What this trial is testing

T-Cell Depleted Double UCB for Refractory AML

Who this might be right for
Acute Myelogenous LeukemiaRefractory Acute Myelogenous Leukemia
Masonic Cancer Center, University of Minnesota 3
Testing effectiveness (Phase 2)UnknownNCT00881933
What this trial is testing

Study of Fludarabine + Cyclophosphamide + TBI Conditioning Regimen for Double Units Cord Blood Transplantation(CBT)in Severe Aplastic Anemia(SAA)

Who this might be right for
Aplastic Anemia
The Korean Society of Pediatric Hematology Oncology 5
Load More Results